Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK621371PMID: 41855368
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1423719-30-5
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of nerandomilast during breastfeeding. Because nerandomilast is about 77% bound to plasma proteins, the amount in milk is likely to be low. If a mother requires nerandomilast, it is not a reason to discontinue breastfeeding. Monitor the breastfed infant for diarrhea, vomiting, and adequate weight gain.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Nerandomilast
CAS Registry Number
1423719-30-5
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Paltusotine.[Drugs and Lactation Database (...]Review Paltusotine.. Drugs and Lactation Database (LactMed®). 2006
- Review Zoliflodacin.[Drugs and Lactation Database (...]Review Zoliflodacin.. Drugs and Lactation Database (LactMed®). 2006
- Review Resmetirom.[Drugs and Lactation Database (...]Review Resmetirom.. Drugs and Lactation Database (LactMed®). 2006
- Review Remibrutinib.[Drugs and Lactation Database (...]Review Remibrutinib.. Drugs and Lactation Database (LactMed®). 2006
- Synthesis of Carbon 14 and Deuterium-Labelled Nerandomilast (BI 1015550).[J Labelled Comp Radiopharm. 2025]Synthesis of Carbon 14 and Deuterium-Labelled Nerandomilast (BI 1015550).Latli B, Hrapchak MJ, Frutos RP. J Labelled Comp Radiopharm. 2025 Jan-Feb; 68(1-2):e4133.
- Nerandomilast - Drugs and Lactation Database (LactMed®)Nerandomilast - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...